Back

Redefining the epidemiology of cardiac amyloidosis. A systematic review of screening studies

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Highlight on cardiomyopathy Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Doctor Alberto Aimo

Sant'Anna School of Advanced Studies, Pisa (Italy)

5 More presentations in this session

Presentation thumbnail
Clinical characterization and natural history of chemotherapy-induced dilated cardiomyopathy
Doctor A. Lalario (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic implication of neutrophil-lymphocyte ratio (NLR) in myocarditis: results from a multicentre, multinational study.
Doctor A. Cannata (London, GB)
Abstract Slides Video
Presentation thumbnail
Exercise oxygen kinetic in hypertrophic cardiomyopathy: results from a multicenter cardiopulmonary exercise testing study
Doctor M. Mapelli (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 mutation
Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Estimating the penetrance of genetic variants linked to cardiomyopathy
Mr R. De Brouwer (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Highlight on cardiomyopathy
Video

The Event

Event poster

Heart Failure 2022

21 May - 24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources